Republicii 198
Pitesti, Arges
Ion Ionescu de la Brad 65
Sector 1, Bucuresti
0700 000 000

Granulator inertization – Capacity expansion


400 million of the world’s population can not access health services, and more than 2 billion can not afford the medicines they need. *Access to health can nevertheless be enhanced if more people are given a preventive disease education, if diagnosed and benefit the right treatment.

Generic drugs are therapeutic equivalents of original pharmaceutical products whose patents have expired.
Are widely used in cost-effective treatment programs and is prescribed by doctors as effective alternatives to more expensive innovative pharmaceutical products.
Generic medicines provide a major benefit to society: ensuring patient access to quality pharmaceutical treatment at affordable costs.


SANDOZ – Novartis Group division- is the second largest global manufacturer of generic drugs and plays an important role in their access to the less developed countries.

Sandoz is also present in Romania through a production facility and generic drugs produced here are exported to over 60 countries.
The manufacturing process requires high quality standards specific to the pharmaceutical industry.

Sandoz Targu Mures benefits for several years of Parker technologies for inerting with nitrogen the granulators with pharmaceutical ingredients.
The second installed NitroFil® generator provides nitrogen production capacity 4 times higher and supports the extension of the manufacturing process.

NitroFil® benefits, after several generations usage: monitoring and automatic generation without the need to change the bottles, aspect that ensures a stable process.

Ștefan Mateaș
Head Maintenance – SANDOZ SRL

In 2015, Sandoz products have reached about 520 million patients and the company’s efforts aimed at reaching the level of one billion population.

More about SANDOZ- Making Access Happen.

* Source

Copyright © 2020